Advertisement

Journal of NeuroVirology

, Volume 25, Issue 5, pp 622–633 | Cite as

Pathogenesis of age-related HIV neurodegeneration

  • Miroslaw (Mack) Mackiewicz
  • Cassia Overk
  • Cristian L. Achim
  • Eliezer MasliahEmail author
Article

Abstract

People over the age of 50 are the fastest growing segment of the HIV-infected population in the USA. Although antiretroviral therapy has remarkable success controlling the systemic HIV infection, HIV-associated neurocognitive disorder (HAND) prevalence has increased or remained the same among this group, and cognitive deficits appear more severe in aged patients with HIV. The mechanisms of HAND in the aged population are not completely understood; a leading hypothesis is that aged individuals with HIV might be at higher risk of developing Alzheimer’s disease (AD) or one of the AD-related dementias (ADRD). There are a number of mechanisms through which chronic HIV disease alone or in combination with antiretroviral therapy and other comorbidities (e.g., drug use, hepatitis C virus (HCV)) might be contributing to HAND in individuals over the age of 50 years, including (1) overlapping pathogenic mechanisms between HIV and aging (e.g., decreased proteostasis, DNA damage, chronic inflammation, epigenetics, vascular), which could lead to accelerated cellular aging and neurodegeneration and/or (2) by promoting pathways involved in AD/ADRD neuropathogenesis (e.g., triggering amyloid β, Tau, or α-synuclein accumulation). In this manuscript, we will review some of the potential common mechanisms involved and evidence in favor and against a role of AD/ADRD in HAND.

Keywords

Aging Alzheimer’s disease HIV-associated cognitive impairment Neurodegeneration 

Notes

Acknowledgments

The authors thank Drs. Jorge R. Barrio, Vladimir Kepe, and Harry V. Vinters at UCLA, and the HIV Neurobehavioral Research Program Developmental Core at UCSD.

Funding information

This study received funding from R01MH105319-04 to CLA.

References

  1. Achim CL, Adame A, Dumaop W, Everall IP, Masliah E, Neurobehavioral Research C (2009) Increased accumulation of intraneuronal amyloid beta in HIV-infected patients. J NeuroImmune Pharmacol 4:190–199PubMedPubMedCentralCrossRefGoogle Scholar
  2. Alakkas A, Ellis RJ, Watson CW, Umlauf A, Heaton RK, Letendre S, Collier A, Marra C, Clifford DB, Gelman B, Sacktor N, Morgello S, Simpson D, McCutchan JA, Kallianpur A, Gianella S, Marcotte T, Grant I, Fennema-Notestine C, Group C (2018) White matter damage, neuroinflammation, and neuronal integrity in HAND. J Neurovirol:1–10Google Scholar
  3. Alirezaei M, Kiosses WB, Flynn CT, Brady NR, Fox HS (2008a) Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS One 3:e2906PubMedPubMedCentralCrossRefGoogle Scholar
  4. Alirezaei M, Kiosses WB, Fox HS (2008b) Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity. Autophagy 4:963–966PubMedPubMedCentralCrossRefGoogle Scholar
  5. Alzheimer’s Association (2013) 2013 Alzheimer’s disease facts and figures. Alzheimer’s Dementia 9:1–71CrossRefGoogle Scholar
  6. Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman DM, Morris JC, Clifford DB (2012) 11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder. Arch Neurol 69:72–77PubMedPubMedCentralGoogle Scholar
  7. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE (2006) Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy. Acta Neuropathol 111:529–538PubMedCrossRefGoogle Scholar
  8. Arai T, Mackenzie IR, Hasegawa M, Nonoka T, Niizato K, Tsuchiya K, Iritani S, Onaya M, Akiyama H (2009) Phosphorylated TDP-43 in Alzheimer’s disease and dementia with Lewy bodies. Acta Neuropathol 117:125–136PubMedCrossRefGoogle Scholar
  9. Avraham HK, Jiang S, Fu Y, Rockenstein E, Makriyannis A, Wood J, Wang L, Masliah E, Avraham S (2015) Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme. Br J Pharmacol 172:4603–4614PubMedPubMedCentralCrossRefGoogle Scholar
  10. Becker JT, Lopez OL, Dew MA, Aizenstein HJ (2004) Prevalence of cognitive disorders differs as a function of age in HIV virus infection. AIDS 18(Suppl 1):S11–S18CrossRefGoogle Scholar
  11. Boban JM, Kozic DB, Brkic SV, Lendak DF, Thurnher MM (2018) Early introduction of cART reverses brain aging pattern in well-controlled HIV infection: a comparative MR spectroscopy study. Front Aging Neurosci 10:329PubMedPubMedCentralCrossRefGoogle Scholar
  12. Boyle PA, Yu L, Leurgans SE, Wilson RS, Brookmeyer R, Schneider JA, Bennett DA (2018) Attributable risk of Alzheimer's dementia attributed to age-related neuropathologies. Ann NeurolGoogle Scholar
  13. Brew BJ (2004) Evidence for a change in AIDS dementia complex in the era of highly active antiretroviral therapy and the possibility of new forms of AIDS dementia complex. AIDS 18(Suppl 1):S75–S78PubMedCrossRefPubMedCentralGoogle Scholar
  14. Brown LA, Scarola J, Smith AJ, Sanberg PR, Tan J, Giunta B (2014) The role of tau protein in HIV-associated neurocognitive disorders. Mol Neurodegener 9:40PubMedPubMedCentralCrossRefGoogle Scholar
  15. Budka H, Costanzi G, Cristina S, Lechi A, Parravicini C, Trabattoni R, Vago L (1987) Brain pathology induced by infection with the human immunodeficiency virus (HIV). A histological, immunocytochemical, and electron microscopical study of 100 autopsy cases. Acta Neuropathol 75:185–198PubMedCrossRefGoogle Scholar
  16. Budka H, Wiley CA, Kleihues P, Artigas J, Asbury AK, Cho ES, Cornblath DR, Dal Canto MC, DeGirolami U, Dickson D et al (1991) HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol 1:143–152PubMedCrossRefGoogle Scholar
  17. Campbell GR, Spector SA (2013) Inhibition of human immunodeficiency virus type-1 through autophagy. Curr Opin Microbiol 16:349–354PubMedPubMedCentralCrossRefGoogle Scholar
  18. Campbell GR, Rawat P, Bruckman RS, Spector SA (2015) Human immunodeficiency virus type 1 Nef inhibits autophagy through transcription factor EB sequestration. PLoS Pathog 11:e1005018PubMedPubMedCentralCrossRefGoogle Scholar
  19. Carroll-Anzinger D, Al-Harthi L (2006) Gamma interferon primes productive human immunodeficiency virus infection in astrocytes. J Virol 80:541–544PubMedPubMedCentralCrossRefGoogle Scholar
  20. CDC (2018) HIV among people aged 50 and olderGoogle Scholar
  21. Chai Q, Jovasevic V, Malikov V, Sabo Y, Morham S, Walsh D, Naghavi MH (2017) HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration. Nat Commun 8:1522PubMedPubMedCentralCrossRefGoogle Scholar
  22. Cherner M, Cysique L, Heaton RK, Marcotte TD, Ellis RJ, Masliah E, Grant I, Group H (2007) Neuropathologic confirmation of definitional criteria for human immunodeficiency virus-associated neurocognitive disorders. J Neurovirol 13:23–28PubMedCrossRefGoogle Scholar
  23. Codogno P, Mehrpour M, Proikas-Cezanne T (2012) Canonical and non-canonical autophagy: variations on a common theme of self-eating? Nat Rev Mol Cell Biol 13:7–12CrossRefGoogle Scholar
  24. Cohen RA, Gullett JM, Porges EC, Woods AJ, Lamb DG, Bryant VE, McAdams M, Tashima K, Cook R, Bryant K, Monnig M, Kahler CW, Monti PM (2018) Heavy alcohol use and age effects on HIV-associated neurocognitive function. Alcohol Clin Exp ResGoogle Scholar
  25. Cole JH, Underwood J, Caan MW, De Francesco D, van Zoest RA, Leech R, Wit FW, Portegies P, Geurtsen GJ, Schmand BA, Schim van der Loeff MF, Franceschi C, Sabin CA, Majoie CB, Winston A, Reiss P, Sharp DJ, collaboration C (2017). Increased brain-predicted aging in treated HIV disease. Neurology 88: 1349–1357PubMedPubMedCentralCrossRefGoogle Scholar
  26. Crews L, Masliah E (2010) Molecular mechanisms of neurodegeneration in Alzheimer’s disease. Hum Mol Genet 19:R12–R20PubMedPubMedCentralCrossRefGoogle Scholar
  27. Crews L, Patrick C, Achim CL, Everall IP, Masliah E (2009) Molecular pathology of neuro-AIDS (CNS-HIV). Int J Mol Sci 10:1045–1063PubMedPubMedCentralCrossRefGoogle Scholar
  28. Crews L, Spencer B, Desplats P, Patrick C, Paulino A, Rockenstein E, Hansen L, Adame A, Galasko D, Masliah E (2010) Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One 5:e9313PubMedPubMedCentralCrossRefGoogle Scholar
  29. Cuervo AM (2004) Autophagy: in sickness and in health. Trends Cell Biol 14:70–77PubMedCrossRefGoogle Scholar
  30. Cuervo AM, Stefanis L, Fredenburg R, Lansbury PT, Sulzer D (2004) Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305:1292–1295PubMedCrossRefPubMedCentralGoogle Scholar
  31. Cysique LA, Hewitt T, Croitoru-Lamoury J, Taddei K, Martins RN, Chew CS, Davies NN, Price P, Brew BJ (2015) APOE epsilon4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study. BMC Neurol 15:51PubMedPubMedCentralCrossRefGoogle Scholar
  32. Daily A, Nath A, Hersh LB (2006) Tat peptides inhibit neprilysin. J Neurovirol 12:153–160PubMedCrossRefPubMedCentralGoogle Scholar
  33. de Almeida SM, Ribeiro CE, Rotta I, Piovesan M, Tang B, Vaida F, Raboni SM, Letendre S, Potter M, Batistela Fernandes MS, Ellis RJ, Group HIVNRC (2018) Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C. J Neurovirol 24:28–40PubMedCrossRefPubMedCentralGoogle Scholar
  34. Desplats P, Dumaop W, Smith D, Adame A, Everall I, Letendre S, Ellis R, Cherner M, Grant I, Masliah E (2013) Molecular and pathologic insights from latent HIV-1 infection in the human brain. Neurology 80:1415–1423PubMedPubMedCentralCrossRefGoogle Scholar
  35. Donaghy PC, McKeith IG (2014) The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimers Res Ther 6:46PubMedPubMedCentralCrossRefGoogle Scholar
  36. Ebrahimi-Fakhari D, Cantuti-Castelvetri I, Fan Z, Rockenstein E, Masliah E, Hyman BT, McLean PJ, Unni VK (2011) Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein. J Neurosci 31:14508–14520PubMedPubMedCentralCrossRefGoogle Scholar
  37. Ellis R, Langford D, Masliah E (2007) HIV and antiretroviral therapy in the brain: neuronal injury and repair. Nat Rev Neurosci 8:33–44PubMedCrossRefPubMedCentralGoogle Scholar
  38. Everall IP, Heaton RK, Marcotte TD, Ellis RJ, McCutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E (1999) Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group HIV Neurobehavioral Research Center. Brain Pathol 9:209–217PubMedCrossRefGoogle Scholar
  39. Everall IP, Hansen LA, Masliah E (2005) The shifting patterns of HIV encephalitis neuropathology. Neurotox Res 8:51–61PubMedCrossRefPubMedCentralGoogle Scholar
  40. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, Letendre S, Moore D, Ellis R, Cherner M, Gelman B, Morgello S, Singer E, Grant I, Masliah E, National Neuro ATC (2009) Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 15:360–370PubMedPubMedCentralCrossRefGoogle Scholar
  41. Fan Y, Gao X, Chen J, Liu Y, He JJ (2016) HIV Tat impairs neurogenesis through functioning as a notch ligand and activation of notch signaling pathway. J Neurosci 36:11362–11373PubMedPubMedCentralCrossRefGoogle Scholar
  42. Fazeli PL, Moore DJ, Franklin DR, Umlauf A, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, Sacktor NC, Morgello S, Simpson DM, McCutchan JA, Grant I, Letendre SL (2016) Lower CSF Abeta is associated with HAND in HIV-infected adults with a family history of dementia. Curr HIV Res 14:324–330PubMedPubMedCentralCrossRefGoogle Scholar
  43. Ferrari R, Kapogiannis D, Huey ED, Momeni P (2011) FTD and ALS: a tale of two diseases. Curr Alzheimer Res 8:273–294PubMedPubMedCentralCrossRefGoogle Scholar
  44. Ferrell D, Giunta B (2014) The impact of HIV-1 on neurogenesis: implications for HAND. Cell Mol Life Sci 71:4387–4392PubMedPubMedCentralCrossRefGoogle Scholar
  45. Fields J, Dumaop W, Rockenstein E, Mante M, Spencer B, Grant I, Ellis R, Letendre S, Patrick C, Adame A, Masliah E (2013) Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer. J Neurovirol 19:89–101PubMedPubMedCentralCrossRefGoogle Scholar
  46. Fields J, Dumaop W, Langford TD, Rockenstein E, Masliah E (2014) Role of neurotrophic factor alterations in the neurodegenerative process in HIV associated neurocognitive disorders. J NeuroImmune Pharmacol 9:102–116PubMedPubMedCentralCrossRefGoogle Scholar
  47. Fields J, Dumaop W, Eleuteri S, Campos S, Serger E, Trejo M, Kosberg K, Adame A, Spencer B, Rockenstein E, He JJ, Masliah E (2015a) HIV-1 Tat alters neuronal autophagy by modulating autophagosome fusion to the lysosome: implications for HIV-associated neurocognitive disorders. J Neurosci 35:1921–1938PubMedPubMedCentralCrossRefGoogle Scholar
  48. Fields JA, Dumaop W, Crews L, Adame A, Spencer B, Metcalf J, He J, Rockenstein E, Masliah E (2015b) Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders. Curr HIV Res 13:43–54PubMedPubMedCentralCrossRefGoogle Scholar
  49. Fields JA, Metcalf J, Overk C, Adame A, Spencer B, Wrasidlo W, Florio J, Rockenstein E, He JJ, Masliah E (2017) The anticancer drug sunitinib promotes autophagyand protects from neurotoxicity in an HIV-1 Tat model of neurodegeneration. J Neurovirol 23:290–303PubMedPubMedCentralCrossRefGoogle Scholar
  50. Geffin R, McCarthy M (2018a) Aging and apolipoprotein E in HIV infection. J Neurovirol 24:529–548PubMedPubMedCentralCrossRefGoogle Scholar
  51. Geffin R, McCarthy M (2018b) Correction to: aging and apolipoprotein E in HIV infection. J Neurovirol 24:813PubMedCrossRefGoogle Scholar
  52. Gendelman HE, Persidsky Y, Ghorpade A, Limoges J, Stins M, Fiala M, Morrisett R (1997) The neuropathogenesis of the AIDS dementia complex. AIDS 11(Suppl A):S35–S45PubMedGoogle Scholar
  53. Goedert M, Jakes R, Anthony Crowther R, Grazia Spillantini M (2001) Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy as alpha-synucleinopathies. Methods Mol Med 62:33–59PubMedPubMedCentralGoogle Scholar
  54. Goedert M, Ghetti B, Spillantini MG (2012) Frontotemporal dementia: implications for understanding Alzheimer disease. Cold Spring Harb Perspect Med 2:a006254PubMedPubMedCentralCrossRefGoogle Scholar
  55. Gonzalez-Scarano F, Martin-Garcia J (2005) The neuropathogenesis of AIDS. Nat Rev Immunol 5:69–81PubMedCrossRefGoogle Scholar
  56. Gozuacik D, Kimchi A (2004) Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23:2891–2906PubMedPubMedCentralCrossRefGoogle Scholar
  57. Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19:407–411Google Scholar
  58. Haas DW, Clough LA, Johnson BW, Harris VL, Spearman P, Wilkinson GR, Fletcher CV, Fiscus S, Raffanti S, Donlon R, McKinsey J, Nicotera J, Schmidt D, Shoup RE, Kates RE, Lloyd RM Jr, Larder B (2000) Evidence of a source of HIV type 1 within the central nervous system by ultraintensive sampling of cerebrospinal fluid and plasma. AIDS Res Hum Retrovir 16:1491–1502PubMedCrossRefPubMedCentralGoogle Scholar
  59. Hategan A, Bianchet MA, Steiner J, Karnaukhova E, Masliah E, Fields A, Lee MH, Dickens AM, Haughey N, Dimitriadis EK, Nath A (2017) HIV Tat protein and amyloid-beta peptide form multifibrillar structures that cause neurotoxicity. Nat Struct Mol Biol 24:379–386PubMedPubMedCentralCrossRefGoogle Scholar
  60. Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, Group C (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER study. Neurology 75:2087–2096PubMedPubMedCentralCrossRefGoogle Scholar
  61. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011a) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neuro-Oncol 17:3–16Google Scholar
  62. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I, Group C, Group H (2011b) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3–16PubMedCrossRefPubMedCentralGoogle Scholar
  63. Hebert LE, Weuve J, Scherr PA, Evans DA (2013) Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80:1778–1783PubMedPubMedCentralCrossRefGoogle Scholar
  64. Hellmuth J, Milanini B, Masliah E, Tartaglia MC, Dunlop MB, Moore DJ, Javandel S, DeVaughn S, Valcour V (2018) A neuropathologic diagnosis of Alzheimer’s disease in an older adult with HIV-associated neurocognitive disorder. Neurocase 24:213–219PubMedPubMedCentralCrossRefGoogle Scholar
  65. International AsD (2016) National Alzheimer’s and dementia plansGoogle Scholar
  66. Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB, Holtzman DM, Jagust W, Jessen F, Karlawish J, Liu E, Molinuevo JL, Montine T, Phelps C, Rankin KP, Rowe CC, Scheltens P, Siemers E, Snyder HM, Sperling R, Contributors (2018) NIA-AA Research framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement 14:535–562PubMedPubMedCentralCrossRefGoogle Scholar
  67. Jaeger PA, Wyss-Coray T (2010) Beclin 1 complex in autophagy and Alzheimer disease. Arch Neurol 67:1181–1184PubMedCrossRefPubMedCentralGoogle Scholar
  68. James BD, Wilson RS, Boyle PA, Trojanowski JQ, Bennett DA, Schneider JA (2016) TDP-43 stage, mixed pathologies, and clinical Alzheimer’s-type dementia. Brain 139:2983–2993PubMedPubMedCentralCrossRefGoogle Scholar
  69. Johnson TP, Patel K, Johnson KR, Maric D, Calabresi PA, Hasbun R, Nath A (2013) Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci U S A 110:13588–13593PubMedPubMedCentralCrossRefGoogle Scholar
  70. Joska JA, Gouse H, Paul RH, Stein DJ, Flisher AJ (2010) Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. J Neurovirol 16:101–114PubMedCrossRefGoogle Scholar
  71. Kaul M, Garden GA, Lipton SA (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988–994PubMedCrossRefPubMedCentralGoogle Scholar
  72. Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, Franceschi C, Lithgow GJ, Morimoto RI, Pessin JE, Rando TA, Richardson A, Schadt EE, Wyss-Coray T, Sierra F (2014) Geroscience: linking aging to chronic disease. Cell 159:709–713PubMedPubMedCentralCrossRefGoogle Scholar
  73. Khanlou N, Moore DJ, Chana G, Cherner M, Lazzaretto D, Dawes S, Grant I, Masliah E, Everall IP, Group H (2009) Increased frequency of alpha-synuclein in the substantia nigra in human immunodeficiency virus infection. J Neurovirol 15:131–138PubMedPubMedCentralCrossRefGoogle Scholar
  74. Kuhn HG, Toda T, Gage FH (2018) Adult hippocampal neurogenesis: a coming-of-age story. J Neurosci 38:10401–10410PubMedPubMedCentralCrossRefGoogle Scholar
  75. Kyei GB, Dinkins C, Davis AS, Roberts E, Singh SB, Dong C, Wu L, Kominami E, Ueno T, Yamamoto A, Federico M, Panganiban A, Vergne I, Deretic V (2009) Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J Cell Biol 186:255–268PubMedPubMedCentralCrossRefGoogle Scholar
  76. Levine AJ, Quach A, Moore DJ, Achim CL, Soontornniyomkij V, Masliah E, Singer EJ, Gelman B, Nemanim N, Horvath S (2016) Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders. J Neurovirol 22:366–375PubMedCrossRefPubMedCentralGoogle Scholar
  77. Lipton SA (1994) AIDS-related dementia and calcium homeostasis. Ann N Y Acad Sci 747:205–224PubMedCrossRefGoogle Scholar
  78. Makitalo S, Mellgren A, Borgh E, Kilander L, Skillback T, Zetterberg H, Gisslen M (2015) The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer's disease. AIDS Res Ther 12:23PubMedPubMedCentralCrossRefGoogle Scholar
  79. Masliah E, Ge N, Achim CL, Wiley CA (1995) Differential vulnerability of calbindin-immunoreactive neurons in HIV encephalitis. J Neuropathol Exp Neurol 54:350–357PubMedCrossRefGoogle Scholar
  80. McKeith IG (2000) Spectrum of Parkinson’s disease, Parkinson’s dementia, and Lewy body dementia. Neurol Clin 18:865–902PubMedCrossRefGoogle Scholar
  81. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Carlos Machado J, O'Brien J, Playfer J, Reid W, International Psychogeriatric Association Expert Meeting on DLB (2004) Dementia with Lewy bodies. Lancet Neurol 3:19–28PubMedCrossRefGoogle Scholar
  82. Milanini B, Valcour V (2017) Differentiating HIV-associated neurocognitive disorders from Alzheimer’s disease: an emerging issue in geriatric NeuroHIV. Curr HIV/AIDS Rep 14:123–132PubMedPubMedCentralCrossRefGoogle Scholar
  83. Mishra M, Taneja M, Malik S, Khalique H, Seth P (2010) Human immunodeficiency virus type 1 Tat modulates proliferation and differentiation of human neural precursor cells: implication in NeuroAIDS. J Neurovirol 16:355–367PubMedCrossRefGoogle Scholar
  84. Mocchetti I, Bachis A, Masliah E (2008) Chemokine receptors and neurotrophic factors: potential therapy against aids dementia? J Neurosci Res 86:243–255PubMedCrossRefGoogle Scholar
  85. Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I, Group H (2006) Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. AIDS 20:879–887PubMedCrossRefGoogle Scholar
  86. Morgan EE, Iudicello JE, Weber E, Duarte NA, Riggs PK, Delano-Wood L, Ellis R, Grant I, Woods SP, Group HIVNRP (2012) Synergistic effects of HIV infection and older age on daily functioning. J Acquir Immune Defic Syndr 61:341–348PubMedPubMedCentralCrossRefGoogle Scholar
  87. Morgello S (2018) HIV neuropathology. Handb Clin Neurol 152:3–19PubMedCrossRefGoogle Scholar
  88. Murray ME, Cannon A, Graff-Radford NR, Liesinger AM, Rutherford NJ, Ross OA, Duara R, Carrasquillo MM, Rademakers R, Dickson DW (2014) Differential clinicopathologic and genetic features of late-onset amnestic dementias. Acta Neuropathol 128:411–421PubMedPubMedCentralCrossRefGoogle Scholar
  89. Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl 2):S193–S198PubMedCrossRefGoogle Scholar
  90. Nath A, Haughey NJ, Jones M, Anderson C, Bell JE, Geiger JD (2000) Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: protection by memantine. Ann Neurol 47:186–194PubMedCrossRefPubMedCentralGoogle Scholar
  91. Nguyen TP, Soukup VM, Gelman BB (2010) Persistent hijacking of brain proteasomes in HIV-associated dementia. Am J Pathol 176:893–902PubMedPubMedCentralCrossRefGoogle Scholar
  92. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM (2005) Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 64:113–122PubMedCrossRefGoogle Scholar
  93. Norman JP, Perry SW, Reynolds HM, Kiebala M, De Mesy Bentley KL, Trejo M, Volsky DJ, Maggirwar SB, Dewhurst S, Masliah E, Gelbard HA (2008) HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization. PLoS One 3:e3731PubMedPubMedCentralCrossRefGoogle Scholar
  94. Patrick C, Crews L, Desplats P, Dumaop W, Rockenstein E, Achim CL, Everall IP, Masliah E (2011) Increased CDK5 expression in HIV encephalitis contributes to neurodegeneration via tau phosphorylation and is reversed with Roscovitine. Am J Pathol 178:1646–1661PubMedPubMedCentralCrossRefGoogle Scholar
  95. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, Small S, Spencer B, Rockenstein E, Levine B, Wyss-Coray T (2008) The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest 118:2190–2199PubMedPubMedCentralGoogle Scholar
  96. Pulliam L (2009) HIV regulation of amyloid beta production. J NeuroImmune Pharmacol 4:213–217PubMedCrossRefGoogle Scholar
  97. Rempel HC, Pulliam L (2005) HIV-1 Tat inhibits neprilysin and elevates amyloid beta. AIDS 19:127–135CrossRefGoogle Scholar
  98. Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, Duda JE, Irwin DJ, Wolk D, Elman L, McCluskey L, Chen-Plotkin A, Weintraub D, Arnold SE, Brettschneider J, Lee VM, Trojanowski JQ (2018) Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain 141:2181–2193PubMedPubMedCentralCrossRefGoogle Scholar
  99. Scott JC, Woods SP, Carey CL, Weber E, Bondi MW, Grant I, Group HIVNRC (2011) Neurocognitive consequences of HIV infection in older adults: an evaluation of the “cortical” hypothesis. AIDS Behav 15:1187–1196PubMedCrossRefGoogle Scholar
  100. Secretary OOTA, Evaluation FPA (2016) National plan to address Alzheimer’s diseaseGoogle Scholar
  101. Seider TR, Gongvatana A, Woods AJ, Chen H, Porges EC, Cummings T, Correia S, Tashima K, Cohen RA (2016) Age exacerbates HIV-associated white matter abnormalities. J Neurovirol 22:201–212PubMedCrossRefGoogle Scholar
  102. Sheppard DP, Woods SP, Massman PJ, Gilbert PE (2018) Frequency and correlates of subjective cognitive impairment in HIV disease. AIDS BehavGoogle Scholar
  103. Sierra F (2016) The emergence of Geroscience as an interdisciplinary approach to the enhancement of health span and life span. Cold Spring Harbor Perspect Med 6:a025163CrossRefGoogle Scholar
  104. Sillman B, Woldstad C, McMillan J, Gendelman HE (2018) Neuropathogenesis of human immunodeficiency virus infection. Handb Clin Neurol 152:21–40PubMedCrossRefGoogle Scholar
  105. Solomon IH, De Girolami U, Chettimada S, Misra V, Singer EJ, Gabuzda D (2017) Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era. BMC Infect Dis 17:151PubMedPubMedCentralCrossRefGoogle Scholar
  106. Soontornniyomkij V, Moore DJ, Gouaux B, Soontornniyomkij B, Tatro ET, Umlauf A, Masliah E, Levine AJ, Singer EJ, Vinters HV, Gelman BB, Morgello S, Cherner M, Grant I, Achim CL (2012) Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers. AIDS 26:2327–2335PubMedPubMedCentralCrossRefGoogle Scholar
  107. Soontornniyomkij V, Umlauf A, Chung SA, Cochran ML, Soontornniyomkij B, Gouaux B, Toperoff W, Moore DJ, Masliah E, Ellis RJ, Grant I, Achim CL (2014) HIV protease inhibitor exposure predicts cerebral small vessel disease. AIDS 28:1297–1306PubMedPubMedCentralCrossRefGoogle Scholar
  108. Soontornniyomkij V, Umlauf A, Soontornniyomkij B, Gouaux B, Ellis RJ, Levine AJ, Moore DJ, Letendre SL (2018) Association of antiretroviral therapy with brain aging changes among HIV-infected adults. AIDS 32:2005–2015PubMedPubMedCentralGoogle Scholar
  109. Spector SA, Zhou D (2008) Autophagy: an overlooked mechanism of HIV-1 pathogenesis and neuroAIDS? Autophagy 4:704–706PubMedPubMedCentralCrossRefGoogle Scholar
  110. Spillantini MG (1999) Parkinson’s disease, dementia with Lewy bodies and multiple system atrophy are alpha-synucleinopathies. Parkinsonism Relat Disord 5:157–162PubMedCrossRefPubMedCentralGoogle Scholar
  111. Toggas SM, Masliah E, Rockenstein EM, Rall GF, Abraham CR, Mucke L (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367:188–193PubMedCrossRefGoogle Scholar
  112. Turner RS, Chadwick M, Horton WA, Simon GL, Jiang X, Esposito G (2016) An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement (Amst) 4:1–5Google Scholar
  113. Valcour V, Paul R (2006) HIV infection and dementia in older adults. Clin Infect Dis 42:1449–1454PubMedCrossRefPubMedCentralGoogle Scholar
  114. Valera E, Spencer B, Masliah E (2016) Immunotherapeutic approaches targeting amyloid-beta, alpha-synuclein, and tau for the treatment of neurodegenerative disorders. Neurotherapeutics 13:179–189PubMedCrossRefPubMedCentralGoogle Scholar
  115. Vinters HV, Zarow C, Borys E, Whitman JD, Tung S, Ellis WG, Zheng L, Chui HC (2018) Review: vascular dementia: clinicopathologic and genetic considerations. Neuropathol Appl Neurobiol 44:247–266PubMedCrossRefPubMedCentralGoogle Scholar
  116. Wendelken LA, Jahanshad N, Rosen HJ, Busovaca E, Allen I, Coppola G, Adams C, Rankin KP, Milanini B, Clifford K, Wojta K, Nir TM, Gutman BA, Thompson PM, Valcour V (2016) ApoE epsilon4 is associated with cognition, brain integrity, and atrophy in HIV over age 60. J Acquir Immune Defic Syndr 73:426–432PubMedPubMedCentralCrossRefGoogle Scholar
  117. Wiley CA, Achim C (1994) Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol 36:673–676PubMedCrossRefGoogle Scholar
  118. Wiley CA, Baldwin M, Achim CL (1996) Expression of HIV regulatory and structural mRNA in the central nervous system. AIDS 10:843–847PubMedCrossRefGoogle Scholar
  119. Winslow AR, Moussaud S, Zhu L, Post KL, Dickson DW, Berezovska O, McLean PJ (2014) Convergence of pathology in dementia with Lewy bodies and Alzheimer’s disease: a role for the novel interaction of alpha-synuclein and presenilin 1 in disease. Brain 137:1958–1970PubMedPubMedCentralCrossRefGoogle Scholar
  120. Xu J, Ikezu T (2009) The comorbidity of HIV-associated neurocognitive disorders and Alzheimer’s disease: a foreseeable medical challenge in post-HAART era. J NeuroImmune Pharmacol 4:200–212PubMedCrossRefGoogle Scholar
  121. Yao H, Duan M, Yang L, Buch S (2012) Platelet-derived growth factor-BB restores human immunodeficiency virus tat-cocaine-mediated impairment of neurogenesis: role of TRPC1 channels. J Neurosci 32:9835–9847PubMedPubMedCentralCrossRefGoogle Scholar
  122. Zahr NM (2018) The aging brain with HIV infection: effects of alcoholism or hepatitis C comorbidity. Front Aging Neurosci 10:56PubMedPubMedCentralCrossRefGoogle Scholar
  123. Zhou D, Masliah E, Spector SA (2011) Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. J Infect Dis 203:1647–1657PubMedPubMedCentralCrossRefGoogle Scholar
  124. Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, Ostrow LW, Rothstein JD, Troncoso JC, Ranum LP (2013) RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci U S A 110:E4968–E4977PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2019

Authors and Affiliations

  • Miroslaw (Mack) Mackiewicz
    • 1
  • Cassia Overk
    • 2
  • Cristian L. Achim
    • 3
  • Eliezer Masliah
    • 1
    • 4
    Email author
  1. 1.Division of NeuroscienceNational Institute on Aging/NIHBethesdaUSA
  2. 2.Department of NeurosciencesUniversity of California San DiegoLa JollaUSA
  3. 3.Department of PsychiatryUniversity of California San DiegoLa JollaUSA
  4. 4.Laboratory of NeurogeneticsNational Institute on Aging/NIHBethesdaUSA

Personalised recommendations